Em alguns casos, tratam-se de nomes portugueses que colaboraram em investigações multicêntricas, dando assim o contributo português em trabalhos de foro internacional.

Estes trabalhos receberam assim o aval positivo das comissões avaliadoras da ECCO fazendo parte dos 1012 abstracts aceites para neste congresso.

Apresentações em formato poster

P252 Assessment of ulcerative colitis using histological

Poster presentations: Clinical: Diagnosis and outcome (2018)

P545 Antigenic response to CT-P13 and remicade in inflammatory bowel disease patients shows similar epitope recognition

Poster presentations: Clinical: Therapy and observation (2018)

P229 The new biosimilar of infliximab SB2 can be quantified by IFX-optimised therapeutic drug monitoring assays

Poster presentations: Clinical: Diagnosis and outcome (2018)

P142 Danese’s “Red flag Instrument” is ready for clinical practice: the RFi prospective validation

Poster presentations: Clinical: Diagnosis and outcome (2018)

P173 Danese’s “Red flag Instrument” for early Crohn’s disease referral may also pick up ulcerative colitis patients – a prospective study

Poster presentations: Clinical: Diagnosis and outcome (2018)

P850 Genetic variants of MGAT5 gene are associated with ulcerative colitis severity and response to therapy

Poster presentations: Genetics (2018)

P014 Proinflammatory cytokines and bile salts inhibit the cellular uptake of butyrate by Caco-2 cells

Poster presentations: Basic science (2018)

P221 Histological indices in ulcerative colitis - useful in predicting long-term recurrence?

Poster presentations: Clinical: Diagnosis and outcome (2018)

P198 Are lower levels of faecal calprotectin reassuring in Crohn´s Disease patients?

Poster presentations: Clinical: Diagnosis and outcome (2018)

P311 Crohn’s disease: What can we expect from the course of the disease?

Poster presentations: Clinical: Diagnosis and outcome (2018)

P812 Natural disease course of inflammatory bowel disease unclassified in a prospective European population-based inception cohort—the Epi-IBD cohort

Poster presentations: Epidemiology (2018)

P402 Interstitial and granulomatous lung disease in inflammatory bowel disease patients

Poster presentations: Clinical: Therapy and observation (2018)

P555 Coagulation disorders in a population of patients with inflammatory bowel disease

Poster presentations: Clinical: Therapy and observation (2018)

P146 Ultrasonography and perianal involvement in inflammatory bowel disease

Poster presentations: Clinical: Diagnosis and outcome (2018)

P236 Symptoms of anxiety and depression in inflammatory bowel disease

Poster presentations: Clinical: Diagnosis and outcome (2018)

P290 Determination of small-bowel patency in Crohn’s disease - a prospective study

Poster presentations: Clinical: Diagnosis and outcome (2018)

P358 Factors associated with disability in inflammatory bowel disease (IBD): A cross-sectional study in outpatients

Poster presentations: Clinical: Diagnosis and outcome (2018)

P355 Prevalence, clinical characteristics and outcomes of CMV colitis in a cohort of 95 patients with ulcerative colitis: A 7-year retrospective analysis

Poster presentations: Clinical: Diagnosis and outcome (2018)

P878 Are cariogenic bacteria the major risk factor for dental caries in patients with ulcerative colitis?

Poster presentations: Microbiology (2018)

P414 Loss of response to anti-TNF in inflammatory bowel disease in a Portuguese centre

Poster presentations: Clinical: Therapy and observation (2018)

P537 Adalimumab: Relevance of drug trough levels and antibodies assessment in the prognosis of Crohn’s disease

Poster presentations: Clinical: Therapy and observation (2018)

P739 Early use of anti-TNF in Crohn’s disease is associated with higher rate of biological and endoscopic remission

Poster presentations: Clinical: Therapy and observation (2018)

P736 Point-of-care infliximab quantification in inflammatory bowel disease in daily practice

Poster presentations: Clinical: Therapy and observation (2018)

P720 Is there a difference in trough levels and immunogenicity between Crohn’s disease and ulcerative colitis patients treated with infliximab?

Poster presentations: Clinical: Therapy and observation (2018)

P126 Post-inflammatory polyps do not predict colorectal neoplasia in patients with inflammatory bowel disease: a multinational retrospective cohort study

Poster presentations: Clinical: Diagnosis and outcome (2018)

P168 Predicting outcome in acute severe ulcerative colitis: Comparison of the Oxford, Edinburgh, Lindgren and endoscopic Mayo scores

Poster presentations: Clinical: Diagnosis and outcome (2018)

P164 Into intimacy: Impact of IBD in sexual health

Poster presentations: Clinical: Diagnosis and outcome (2018)

P263 Evaluation of fatigue in inflammatory bowel disease: a useful tool in daily practice

Poster presentations: Clinical: Diagnosis and outcome (2018)

P285 Crohn’s disease overall severity is predictive of disabling disease: Disease severity index evaluation

Poster presentations: Clinical: Diagnosis and outcome (2018)

P873 The psycho-emotional experience of pregnancy in women with IBD and correlation with gut microbiome

Poster presentations: Microbiology (2018)

Digital Oral Presentations:

DOP019 Immunomodulators reduce the risk of surgery and hospitalisation in Crohn’s disease in a prospective European population-based inception cohort: the Epi-IBD cohort

DOP Session 3 - Old and new immunomodulators 2018

DOP087 The gut microbiota of pregnant women with Crohn’s disease and their babies is associated with abnormalities in the adaptive immune system: results from the MECONIUM study

DOP Session 10 - Microbes, food and cancer in IBD 2018